Dr Barry Hardy

Dr Barry Hardy

Job Title: 
Chief Executive Officer (CEO)

Dr Barry Hardy coordinates the OpenTox project in predictive toxicology and the ToxBank infrastructure development project. He currently leads the infrastructure development for the IMI EBiSC stem cell banking project and eNanoMapper supporting nanotechnology safety assessment.

He has led the development of research and best practice activities in drug design and toxicology through founding the eCheminfo Community of Practice, InnovationWell and Scientists Against Malaria project.

His current main focus is developing the DC team, working with the community, partners and stakeholders to bring high quality solutions to the market providing business benefit to customers, and in turn protecting the health and environment of all consumers

Dr. Hardy obtained his Ph.D. in 1990 from Syracuse University working in computational science. He was a National Research Fellow at the FDA Center for Biologics and Evaluation, a Hitchings-Elion Fellow at Oxford University and CEO of Virtual Environments International.

He was a pioneer in the early 1990s in the development of Web technology applied to virtual scientific communities and conferences. He has developed technology solutions for internet-based communications, tutor-supported e-learning, laboratory automation systems, and computational science and informatics.

In recent years he has been active in the field of knowledge management as applied to supporting innovation, communities of practice, and collaboration.

Latest Tweets

Douglas Connect (3 days ago)
Deadline of the early-bird rate and the bursary applications for the #eChemInfo workshop is less then one week away. https://t.co/NxBAmGIFtz
Douglas Connect (3 weeks ago)
RT @barryhardy: #OpenTox Asia 2017 detailed program available #toxicology #safety #risk #3Rs #insilico #invitro #Korea @DouglasConn https:/…
Douglas Connect (4 weeks ago)
Your input is needed to the #OpenRiskNet eInfrastructure design supporting #datasharing #modelling #RiskAssessment https://t.co/ANfwQRpqVj
Douglas Connect (4 weeks ago)
"2nd Announcement for the eChemInfo Training and Innovation Course in Drug Design 2017 in Milano" https://t.co/iYP1zNEWTX on @LinkedIn
Douglas Connect (6 weeks ago)
RT @eNanoMapper: Protégé 5.2.0 released https://t.co/TGg7V4e03v (our tutorial on how to use it for our ontology: https://t.co/Dv00XOzyyB)

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com